Age-related macular degeneration
Trovati 17 articoli
- Lower risk of age-related macular disease associated with higher intake of fish and Vitamin-D levels
- Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of Vitamin D may have a reduced risk of the early stages of the disease. Age-related m... (Leggi Articolo)
- Age-related macular degeneration: smoking may strongly increase long-term risk
- Current and past smokers appear to have a higher risk of developing late age-related macular degeneration than those who have never smoked. Age-related macular degeneration ( AMD ) is the leading cause of blindness in the Western world. In addition to smoking, AMD is postulated to share other... (Leggi Articolo)
- Genetics and lifestyle interact to increase risk for age-related macular degeneration
- The interplay between genetic predisposition and exposure to modifiable risk factors can multiply the risk for age-related macular degeneration. Age-related macular degeneration ( AMD ) can cause blindness and is known to have both genetic and environmental risk factors. Researchers have prev... (Leggi Articolo)
- Macular degeneration may be linked to quality of dietary carbohydrates
- Age-related macular degeneration ( AMD ), one of the leading causes of vision loss in older adults and a person's risk may partly depend upon diet, could be due to quality of carbohydrates, rather than quantity. Their findings were reported in the American Journal of Clinical Nutrition. Ta... (Leggi Articolo)
- High levels of homocysteine may be linked to increased age-related macular degeneration risk
- People who have elevated homocysteine in their blood, an amino acid that is a known biomarker for cardiovascular disease, may also be at an increased risk of developing age-related macular degeneration ( AMD ). The study is published in the American Journal of Ophthalmology. This research w... (Leggi Articolo)
- Age-related macular degeneration: two genes, Factor H and Factor B, involved
- A study, led by researchers at Columbia University Medical Center and published in Nature Genetics, pinpoints the role that two genes, Factor H and Factor B, play in the development of nearly three out of four cases of age-related macular degeneration ( AMD ), a devastating eye disease that affec... (Leggi Articolo)
- Lucentis in wet age-related macular degeneration, FDA approved
- The FDA ( Food and Drug Administration ) has approved Lucentis ( Ranibizumab injection ) for the treatment of patients with neovascular (wet) age-related macular degeneration ( AMD ). Age-related macular degeneration, a retinal disease causing severe and irreversible vision loss, is a major ca... (Leggi Articolo)
- Fish oil may help protect against retinal degenerative diseases
- A paper published in Trends in Neuroscience by Nicolas G. Bazan, at Louisiana State University ( LSU ) Health Sciences Center in New Orleans, reports on the role that the omega-3 fatty acids in fish oil play in protecting cells in the retina from degenerative diseases like retinitis pigmentosa an... (Leggi Articolo)
- Pegaptanib: rare cases of anaphylaxis or anaphylactoid reactions
- Rare cases of anaphylaxis/anaphylactoid reactions, including angioedema, have been reported in the post-marketing experience following the Macugen ( Pegaptanib sodium injection ) intravitreal administration procedure Macugen is indicated for the treatment of neovascular ( wet ) age-related ma... (Leggi Articolo)
- Chlamydia pneumoniae present in eyes with wet age-related macular degeneration
- Researchers at the Massachusetts Eye and Ear Infirmary ( MEEI ) have found that Chlamydia pneumoniae, a bacterium linked to heart disease and capable of causing chronic inflammation, was present in the diseased eye tissue of five out of nine people with neovascular, or "wet," age-related macular ... (Leggi Articolo)
- Dietary intake of antioxidants linked to reduced risk of age-related macular degeneration
- A study, published in the JAMA, has found that a diet with a high intake of beta carotene, vitamins C and E, and zinc is associated with a substantially reduced risk of age-related macular degeneration in elderly persons. Age-related macular degeneration ( AMD ) is a degenerative disorder of t... (Leggi Articolo)
- Macugen in treatment of diabetic macular edema
- Imaging data from a Phase 2 study of Pegaptanib ( Macugen ) in diabetic macular edema ( DME ) showed a reversal of capillary microaneurysms, retinal ischemia and neovascularization -- all important signs of diabetic retinopathy. Macugen is indicated in the United States for the treatment o... (Leggi Articolo)
- Wet age-related macular degeneration, Lucentis improves vision
- A Phase III clinical trial of the drug Ranibizumab ( Lucentis ) met its primary efficacy endpoint of maintaining vision in patients with wet age-related macular degeneration (AMD ). Approximately 95 percent of patients maintained or improved vision ( defined as a loss of less than 15 letters... (Leggi Articolo)
- Novartis, new products portfolio
- Novartis has a comprehensive portfolio of cardiovascular products both in the market ( Diovan and Lotrel ) as well as in development ( such as LAF237 and SPP100 ), for the treatment of hypertension, dyslipidemia and diabetes. Other compounds in development include APP018 ( D-4F ), an oral Apo ... (Leggi Articolo)
- Early treatment of macular degeneration with Macugen may help patients preserve their vision
- Age-related macular degeneration ( AMD ) is the leading cause of blindness in older patients in the developed world. Vascular endothelial growth factor is one of the key mediators stimulating the abnormal blood vessel growth and leakage characteristic of the exudative ( wet ) form of the cond... (Leggi Articolo)
- Wet age-related macular degeneration, Lucentis and Visudyne combination maintains or improves vision in 90% of patients
- A single-masked Phase I/II clinical study of the investigational drug Lucentis ( Ranibizumab ) met its primary efficacy endpoint of maintaining vision in patients with wet age-related macular degeneration ( AMD ) when used in combination with Verteporfin ( Visudyne ) photodynamic therapy ( PDT ).... (Leggi Articolo)
- HapMap Consortium has published map of human genetic variation
- The International HapMap Consortium published a comprehensive catalog of human genetic variation, a landmark achievement that is already accelerating the search for genes involved in common diseases, such as asthma, diabetes, cancer and heart disease. In a paper in the journal Nature, more th... (Leggi Articolo)
